World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
33759
World Ranking
16419
National Ranking
622

Corrie A.M. Marijnen publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Corrie A.M. Marijnen sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 345 publications — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Corrie A.M. Marijnen D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Corrie A.M. Marijnen sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 81 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Corrie A.M. Marijnen is affiliated with Leiden University Medical Center in the Netherlands. Their research primarily focuses on the field of medicine, with a strong emphasis on oncology, surgery, radiology, nuclear medicine and imaging, radiation, and pulmonary and respiratory medicine.

Their main topics of work cover colorectal cancer surgical treatments, colorectal and anal carcinomas, colorectal cancer screening and detection, advanced radiotherapy techniques, radiomics and machine learning in medical imaging, colorectal cancer treatments and studies, as well as gastric cancer management and outcomes.

Corrie A.M. Marijnen has contributed to a significant number of publications in various journals. Frequent publication venues include:

  • Radiotherapy and Oncology
  • European Journal of Surgical Oncology
  • Clinical and Translational Radiation Oncology
  • International Journal of Radiation Oncology*Biology*Physics
  • British Journal of Surgery

Notable recent papers involving Corrie A.M. Marijnen include:

  • Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial, 2020, The Lancet Oncology
  • Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery, 2023, Annals of Surgery
  • International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer, 2021, Nature Reviews Clinical Oncology
  • Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer - Results of the international randomized RAPIDO-trial, 2020, Radiotherapy and Oncology
  • Short-course radiotherapy followed by chemotherapy before TME in locally advanced rectal cancer: The randomized RAPIDO trial., 2020, Journal of Clinical Oncology

Several frequent co-authors have collaborated extensively with Corrie A.M. Marijnen, such as:

  • Geerard L. Beets
  • Geke A.P. Hospers
  • Boudewijn van Etten
  • Per J. Nilsson
  • Femke P. Peters

Best Publications

  • Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer

    Ellen Kapiteijn;Corrie A.M. Marijnen;Iris D. Nagtegaal;Hein Putter

  • Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial

    Willem van Gijn;Carrie A. M. Marijnen;Iris D. Nagtegaal;Elma Meershoek-Klein Kranenbarg

  • The TME Trial After a Median Follow-Up of 6 Years: Increased Local Control but No Survival Benefit in Irradiated Patients With Resectable Rectal Carcinoma

    Koen C. M. J. Peeters;Corrie A. M. Marijnen;Iris D. Nagtegaal;Elma Klein Kranenbarg

  • Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer : Increased bowel dysfunction in irradiated patients - A dutch colorectal cancer group study

    K.C.M.J. Peeters;C.J.H. van de Velde;J.W.H. Leer;H. Martijn

  • Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.

    Renu R Bahadoer;Esmée A Dijkstra;Boudewijn van Etten;Corrie A M Marijnen;Corrie A M Marijnen

  • Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit.

    Iris D. Nagtegaal;Corrie A. M. Marijnen;Elma Klein Kranenbarg;Cornelis J. H. Van De Velde

  • Risk factors for anastomotic failure after total mesorectal excision of rectal cancer

    K. C. M. J. Peeters;R. A. E. M. Tollenaar;C. A. M. Marijnen;E. Klein Kranenbarg

  • Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial.

    C. A.M. Marijnen;E. Kapiteijn;C. J.H. van de Velde;H. Martijn

  • Low Rectal Cancer: A Call for a Change of Approach in Abdominoperineal Resection

    Iris D. Nagtegaal;Cornelius J.H. van de Velde;Corrie A.M. Marijnen;Jan H.J.M. van Krieken

  • Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: Report of a multicenter randomized trial

    Corrie A.M. Marijnen;Cornelis J.H. van de Velde;Hein Putter;Mandy van den Brink

  • Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer

    Ramon Salazar;Paul Roepman;Gabriel Capella;Victor Moreno

  • EURECCA colorectal: Multidisciplinary management: European consensus conference colon & rectum

    Cornelis J.H. Van De Velde;Petra G. Boelens;Josep M. Borras;Jan Willem Coebergh

  • Prediction of survival in patients with metastases in the spinal column: results based on a randomized trial of radiotherapy.

    Yvette M. van der Linden;Sander P. D. S. Dijkstra M.D.;Ernest J. A. Vonk;Corrie A. M. Marijnen M.D.

  • No Downstaging After Short-Term Preoperative Radiotherapy in Rectal Cancer Patients

    C.A.M. Marijnen;I.D. Nagtegaal;E. Klein Kranenbarg;J. Hermans

  • Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial

    A. J. Breugom;W. van Gijn;E. W. Muller;Åke Berglund

  • Single fraction radiotherapy is efficacious: a further analysis of the Dutch Bone Metastasis Study controlling for the influence of retreatment.

    Yvette M van der Linden;Judith J Lok;Elsbeth Steenland;Hendrik Martijn

  • Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial

    M. Kusters;C.A.M. Marijnen;C.J.H. van de Velde;H.J.T. Rutten

  • Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial

    C.A.M Marijnen;I.D Nagtegaal;E Kapiteijn;E.Klein Kranenbarg

  • Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer – the RAPIDO trial

    Per J. Nilsson;Boudewijn van Etten;Geke A. P. Hospers;Lars Pahlman

  • DUTCH COLORECTAL CANCER GROUP. PREOPERATIVE RADIOTHERAPY COMBINED WITH TOTAL MESORECTAL EXCISION FOR RESECTABLE RECTAL CANCER

    E Kapiteijn;C A Marijnen;I D Nagtegaal;H Putter

Frequent Co-Authors

Iris D. Nagtegaal
Iris D. Nagtegaal Radboud University
Cornelis J.H. van de Velde
Cornelis J.H. van de Velde Leiden University Medical Center
Hein Putter
Hein Putter Leiden University Medical Center
Anne M. Stiggelbout
Anne M. Stiggelbout Leiden University Medical Center
Regina G. H. Beets-Tan
Regina G. H. Beets-Tan Antoni van Leeuwenhoek Hospital
Bengt Glimelius
Bengt Glimelius Uppsala University
Pieter J. Tanis
Pieter J. Tanis University of Amsterdam
Geerard L. Beets
Geerard L. Beets Antoni van Leeuwenhoek Hospital
Lars Påhlman
Lars Påhlman Uppsala University
Claus Rödel
Claus Rödel Goethe University Frankfurt

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA can open doors to a variety of healthcare degrees and career opportunities beyond traditional medical school. Many students consider nursing as a pathway, but a common question is, do all nursing schools require the teas? The answer varies by school, and some institutions offer flexible admissions without these exam requirements.

For those interested in the administrative side of healthcare, earning a healthcare administration degree online accredited can lead to rewarding roles managing hospitals, clinics, or healthcare systems. These accredited programs offer the flexibility to study from anywhere while preparing you for leadership positions.

Registered nurses looking to advance their careers may pursue specialized training through rn to fnp programs, making it easier to become a Family Nurse Practitioner with bridge options that streamline the process.

Nutrition is another growing field in healthcare. Earning an online bachelor's in nutrition allows students to explore the science of diet and health, opening opportunities in clinical, community, or wellness roles.

Each of these career pathways can complement or provide alternatives to the traditional medical route, offering flexible online options to launch or advance your career in healthcare.

Best Scientists Citing Corrie A.M. Marijnen

Trending Scientists

Recently Published Articles